{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:11:46Z","timestamp":1789755106895,"version":"4.0.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81373262"],"award-info":[{"award-number":["81373262"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019542","name":"Basic Research Project of Wenzhou City","doi-asserted-by":"publisher","award":["Y20220206"],"award-info":[{"award-number":["Y20220206"]}],"id":[{"id":"10.13039\/501100019542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018553","name":"Science and Technology Plan Project of Wenzhou Municipality","doi-asserted-by":"publisher","award":["H2020006"],"award-info":[{"award-number":["H2020006"]}],"id":[{"id":"10.13039\/501100018553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY16B020010"],"award-info":[{"award-number":["LY16B020010"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY20H300003"],"award-info":[{"award-number":["LY20H300003"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY21B020011"],"award-info":[{"award-number":["LY21B020011"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008867","name":"Department of Education of Zhejiang Province","doi-asserted-by":"publisher","award":["Y202249707"],"award-info":[{"award-number":["Y202249707"]}],"id":[{"id":"10.13039\/501100008867","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.cellsig.2026.112838","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T22:42:45Z","timestamp":1787438565000},"page":"112838","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mut-p53 acts as a synthetic lethal partner with E2F3 inhibition in gastric cancer under FGFR1 inhibitor"],"prefix":"10.1016","volume":"149","author":[{"given":"Sijia","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanxi","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyu","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peizhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanneng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouyang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yejun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guorong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faqing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigui","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2026.112838_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216470","article-title":"Setd2 deficiency promotes gastric tumorigenesis through inhibiting the SIRT1\/FOXO pathway","volume":"579","author":"Feng","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cellsig.2026.112838_bb0010","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12943-023-01761-7","article-title":"Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF\/FGFR signaling in tumor microenvironment","volume":"22","author":"Ruan","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cellsig.2026.112838_bb0015","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1038\/s41416-023-02413-9","article-title":"Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II study","volume":"129","author":"Duffaud","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cellsig.2026.112838_bb0020","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1186\/s12967-023-04450-7","article-title":"Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor microRNAs","volume":"21","author":"Pace","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cellsig.2026.112838_bb0025","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.tips.2016.10.003","article-title":"Therapeutics targeting FGF Signaling network in human diseases","volume":"37","author":"Katoh","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.cellsig.2026.112838_bb0030","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/bjc.2011.603","article-title":"FGFR2 gene amplification and clinicopathological features in gastric cancer","volume":"106","author":"Matsumoto","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cellsig.2026.112838_bb0035","doi-asserted-by":"crossref","first-page":"7438","DOI":"10.1021\/acs.jmedchem.3c00150","article-title":"Discovery of a selective and orally bioavailable FGFR2 degrader for treating gastric Cancer","volume":"66","author":"Ma","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cellsig.2026.112838_bb0040","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1016\/j.apsb.2023.07.018","article-title":"A high-throughput Gaussia luciferase reporter assay for screening potential gasdermin E activators against pancreatic cancer","volume":"13","author":"Liu","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.cellsig.2026.112838_bb0045","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S1470-2045(23)00446-1","article-title":"Pembrolizumab plus lenvatinib in second-line and third-line patients with pleural mesothelioma (PEMMELA): a single-arm phase 2 study","volume":"24","author":"Douma","year":"2023","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.cellsig.2026.112838_bb0050","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00018-023-04729-4","article-title":"Receptor tyrosine kinase inhibitors in cancer","volume":"80","author":"Ebrahimi","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cellsig.2026.112838_bb0055","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc2693","article-title":"When mutants gain new powers: news from the mutant p53 field","volume":"9","author":"Brosh","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cellsig.2026.112838_bb0060","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ncb2641","article-title":"p53 mutations in cancer","volume":"15","author":"Muller","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cellsig.2026.112838_bb0065","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13148-023-01579-6","article-title":"KDM4C-mediated senescence defense is a targetable vulnerability in gastric cancer harboring TP53 mutations","volume":"15","author":"Wang","year":"2023","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.cellsig.2026.112838_bb0070","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12943-016-0546-y","article-title":"Synthetic lethality in lung cancer and translation to clinical therapies","volume":"15","author":"Leung","year":"2016","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cellsig.2026.112838_bb0075","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrg.2017.47","article-title":"Synthetic lethality and cancer","volume":"18","author":"O\u2019Neil","year":"2017","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.cellsig.2026.112838_bb0080","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1080\/14756366.2018.1460824","article-title":"Design, synthesis and biological evaluation of 4-bromo-N-(3,5-dimethoxyphenyl)benzamide derivatives as novel FGFR1 inhibitors for treatment of non-small cell lung cancer","volume":"33","author":"Xie","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.cellsig.2026.112838_bb0085","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.devcel.2004.05.012","article-title":"E2F3-a novel repressor of the ARF\/p53 pathway","volume":"6","author":"Ginsberg","year":"2004","journal-title":"Dev. Cell"},{"key":"10.1016\/j.cellsig.2026.112838_bb0090","doi-asserted-by":"crossref","DOI":"10.1172\/JCI162479","article-title":"CDK4-E2F3 signals enhance oxidative skeletal muscle fiber numbers and function to affect myogenesis and metabolism","volume":"133","author":"Bahn","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellsig.2026.112838_bb0095","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1016\/j.apsb.2021.01.002","article-title":"Cyclin-dependent kinases-based synthetic lethality: evidence, concept, and strategy","volume":"11","author":"Li","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.cellsig.2026.112838_bb0100","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.7150\/ijbs.82566","article-title":"MDM2 inhibition is synthetic lethal with PTEN loss in colorectal cancer cells via the p53-dependent mechanism","volume":"19","author":"Ren","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.cellsig.2026.112838_bb0105","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.canlet.2020.10.003","article-title":"A novel cytarabine analog evokes synthetic lethality by targeting MK2 in p53-deficient cancer cells","volume":"497","author":"Song","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cellsig.2026.112838_bb0110","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ccr.2006.11.024","article-title":"p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK\/MK2 pathway for survival after DNA damage","volume":"11","author":"Reinhardt","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cellsig.2026.112838_bb0115","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1038\/onc.2012.296","article-title":"Forced activation of Cdk1 via wee1 inhibition impairs homologous recombination","volume":"32","author":"Krajewska","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.cellsig.2026.112838_bb0120","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1038\/s41467-023-40352-4","article-title":"Gain-of-function mutant p53 together with ERG proto-oncogene drive prostate cancer by beta-catenin activation and pyrimidine synthesis","volume":"14","author":"Ding","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellsig.2026.112838_bb0125","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s13046-023-02785-z","article-title":"Mutant p53-ENTPD5 control of the calnexin\/calreticulin cycle: a druggable target for inhibiting integrin-\u03b15-driven metastasis","volume":"42","author":"Pavlakis","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2026.112838_bb0130","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.3892\/mmr.2014.3004","article-title":"Deoxycholic acid inhibits the growth of BGC-823 gastric carcinoma cells via a p53-mediated pathway","volume":"11","author":"Yang","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cellsig.2026.112838_bb0135","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.lfs.2017.04.021","article-title":"1,25-Dihydroxyvitamin D(3) suppresses gastric cancer cell growth through VDR- and mutant p53-mediated induction of p21","volume":"179","author":"Li","year":"2017","journal-title":"Life Sci."},{"key":"10.1016\/j.cellsig.2026.112838_bb0140","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1002\/jcp.26190","article-title":"Curcumin regulates proliferation, autophagy, and apoptosis in gastric cancer cells by affecting PI3K and P53 signaling","volume":"233","author":"Fu","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.cellsig.2026.112838_bb0145","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jep.2018.11.028","article-title":"Ethanolic extract of cordyceps cicadae exerts antitumor effect on human gastric cancer SGC-7901 cells by inducing apoptosis, cell cycle arrest and endoplasmic reticulum stress","volume":"231","author":"Xie","year":"2019","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.cellsig.2026.112838_bb0150","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1177\/0960327119855128","article-title":"Apoptosis-promoting and migration-suppressing effect of alantolactone on gastric cancer cell lines BGC-823 and SGC-7901 via regulating p38MAPK and NF-\u03baB pathways","volume":"38","author":"He","year":"2019","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.cellsig.2026.112838_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172528","article-title":"\u0392-Cryptoxanthin induced anti-proliferation and apoptosis by G0\/G1 arrest and AMPK signal inactivation in gastric cancer","volume":"859","author":"Gao","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cellsig.2026.112838_bb0160","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41586-020-2541-0","article-title":"The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic","volume":"586","author":"Kadosh","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cellsig.2026.112838_bb0165","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.semcancer.2023.03.004","article-title":"Role of E2F transcription factor in oral cancer: recent insight and advancements","volume":"92","author":"Kassab","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.cellsig.2026.112838_bb0170","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20181264","article-title":"Prognostic values of E2F mRNA expression in human gastric cancer","volume":"38","author":"Manicum","year":"2018","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.cellsig.2026.112838_bb0175","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1007\/s10620-015-3782-x","article-title":"MiR-141 inhibits gastric Cancer proliferation by interacting with long noncoding RNA MEG3 and Down-regulating E2F3 expression","volume":"60","author":"Zhou","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.cellsig.2026.112838_bb0180","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.3892\/mmr.2014.2567","article-title":"Reduced miR-125a-5p expression is associated with gastric carcinogenesis through the targeting of E2F3","volume":"10","author":"Xu","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cellsig.2026.112838_bb0185","doi-asserted-by":"crossref","first-page":"7049","DOI":"10.1038\/s41598-023-34161-4","article-title":"Synthetic lethality prediction in DNA damage repair, chromatin remodeling and the cell cycle using multi-omics data from cell lines and patients","volume":"13","author":"Markowska","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellsig.2026.112838_bb0190","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/nsmb.1669","article-title":"The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis","volume":"16","author":"Fontemaggi","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.cellsig.2026.112838_bb0195","doi-asserted-by":"crossref","first-page":"391","DOI":"10.4161\/cc.7.3.5286","article-title":"E2F1 and E2F3 activate ATM through distinct mechanisms to promote E1A-induced apoptosis","volume":"7","author":"Hong","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.cellsig.2026.112838_bb0200","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/nature08544","article-title":"Division and apoptosis of E2f-deficient retinal progenitors","volume":"462","author":"Chen","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.cellsig.2026.112838_bb0205","doi-asserted-by":"crossref","first-page":"743","DOI":"10.7150\/ijbs.5345","article-title":"Elevated miR-34c-5p mediates dermal fibroblast senescence by ultraviolet irradiation","volume":"9","author":"Zhou","year":"2013","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.cellsig.2026.112838_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006942","article-title":"A \u2018synthetic-sickness\u2019 screen for senescence re-engagement targets in mutant cancer backgrounds","volume":"13","author":"Cairney","year":"2017","journal-title":"PLoS Genet."},{"key":"10.1016\/j.cellsig.2026.112838_bb0215","article-title":"CircARVCF contributes to cisplatin resistance in gastric Cancer by altering miR-1205 and FGFR1","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.cellsig.2026.112838_bb0220","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20181258","article-title":"MicroRNA-198 inhibits proliferation and induces apoptosis by directly suppressing FGFR1 in gastric cancer","volume":"39","author":"Gu","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.cellsig.2026.112838_bb0225","doi-asserted-by":"crossref","first-page":"434","DOI":"10.23736\/S0031-0808.19.03709-1","article-title":"Long non-coding RNA PROX1-AS1 promotes the proliferation and migration in gastric cancer by epigenetically activating FGFR1","volume":"65","author":"Jiang","year":"2023","journal-title":"Panminerva Med."},{"key":"10.1016\/j.cellsig.2026.112838_bb0230","article-title":"Design and synthesis of novel nordihydroguaiaretic acid (NDGA) analogues as potential FGFR1 kinase inhibitors with anti-gastric activity and Chemosensitizing effect","volume":"11","author":"Chen","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cellsig.2026.112838_bb0235","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ejmech.2016.10.066","article-title":"Synthesis, biological evaluation, QSAR and molecular dynamics simulation studies of potential fibroblast growth factor receptor 1 inhibitors for the treatment of gastric cancer","volume":"127","author":"Ying","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cellsig.2026.112838_bb0240","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s10495-017-1361-7","article-title":"A novel non-ATP competitive FGFR1 inhibitor with therapeutic potential on gastric cancer through inhibition of cell proliferation, survival and migration","volume":"22","author":"Wu","year":"2017","journal-title":"Apoptosis"},{"key":"10.1016\/j.cellsig.2026.112838_bb0245","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1007\/s10120-020-01088-y","article-title":"Resistance to FGFR1-targeted therapy leads to autophagy via TAK1\/AMPK activation in gastric cancer","volume":"23","author":"Peng","year":"2020","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.cellsig.2026.112838_bb0250","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/s41588-018-0204-y","article-title":"Mutational processes shape the landscape of TP53 mutations in human cancer","volume":"50","author":"Giacomelli","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cellsig.2026.112838_bb0255","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.18632\/oncotarget.23513","article-title":"MiR-361-5p suppresses chemoresistance of gastric cancer cells by targeting FOXM1 via the PI3K\/Akt\/mTOR pathway","volume":"9","author":"Tian","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellsig.2026.112838_bb0260","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.3892\/or.2017.5967","article-title":"Low heme oxygenase-1 expression promotes gastric cancer cell apoptosis, inhibits proliferation and invasion, and correlates with increased overall survival in gastric cancer patients","volume":"38","author":"Ren","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.cellsig.2026.112838_bb0265","article-title":"Regorafenib inhibited gastric cancer cells growth and invasion via CXCR4 activated Wnt pathway","volume":"12","author":"Lin","year":"2017","journal-title":"PLoS One"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826004961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826004961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:44:21Z","timestamp":1789753461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826004961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":53,"alternative-id":["S0898656826004961"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112838","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mut-p53 acts as a synthetic lethal partner with E2F3 inhibition in gastric cancer under FGFR1 inhibitor","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112838","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112838"}}